CUSIP: 670108109
Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
414,164
-
Share change
-
+9,853
-
Total reported value
-
$18,838,000
-
Price per share
-
$45.49
-
Number of holders
-
16
-
Value change
-
+$424,585
-
Number of buys
-
10
-
Number of sells
-
4
Quarterly Holders Quick Answers
What is CUSIP 670108109?
CUSIP 670108109 identifies NVZMY - NOVOZYMES AS/FI - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2020
-
Previous quarter:
Q4 2019
Recent filing periods for CUSIP 670108109:
Institutional Holders of NOVOZYMES AS/FI - COM (NVZMY) as of Q1 2020
As of 31 Mar 2020,
NOVOZYMES AS/FI - COM (NVZMY) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
414,164 shares.
The largest 10 holders included
Parametric Portfolio Associates LLC, ZEVIN ASSET MANAGEMENT LLC, PNC Financial Services Group, Inc., HANTZ FINANCIAL SERVICES, INC., Hemenway Trust Co LLC, Douglass Winthrop Advisors, LLC, IRONWOOD INVESTMENT MANAGEMENT LLC, Moloney Securities Asset Management, LLC, HIGH POINTE CAPITAL MANAGEMENT LLC, and CAPTRUST FINANCIAL ADVISORS.
This page lists
16
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.